Getagraph.com logo
S&P 500
(0.22%) 5 111.29 points
Dow Jones
(0.18%) 38 310 points
Nasdaq
(0.22%) 15 964 points
Oil
(-1.34%) $82.73
Gas
(3.90%) $1.998
Gold
(0.03%) $2 347.90
Silver
(-0.10%) $27.51
Platinum
(3.60%) $955.25
USD/EUR
(-0.20%) $0.933
USD/NOK
(-0.33%) $10.99
USD/GBP
(-0.44%) $0.797
USD/RUB
(1.71%) $93.44

Echtzeitaktualisierungen für Benitec Biopharma Inc [BNTC]

Börse: NASDAQ Sektor: Healthcare Industrie: Biotechnology
Zuletzt aktualisiert29 Apr 2024 @ 17:07
25% discount on Stockinvest.us - Use code: Podcast

3.32% $ 7.21

Live Chart Being Loaded With Signals

Commentary (29 Apr 2024 @ 17:07):
Profile picture for Benitec Biopharma Inc

Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions...

Stats
Tagesvolumen 5 355.00
Durchschnittsvolumen 82 838.00
Marktkapitalisierung 18.69M
EPS $0 ( 2024-02-12 )
Nächstes Ertragsdatum ( $-0.780 ) 2024-05-13
Last Dividend $0.0450 ( 2018-06-01 )
Next Dividend $0 ( N/A )
P/E -0.0300
ATR14 $0.0510 (0.71%)
Insider Trading
Date Person Action Amount type
2024-03-06 Banks Jerel A. Buy 466 554 Options (right to buy)
2024-03-06 Boston Megan Buy 200 004 Options (right to buy)
2023-12-06 Smith Edward F Buy 35 000 Options (right to buy)
2023-12-06 Francis Peter Buy 35 000 Options (right to buy)
2023-12-06 Buchi J Kevin Buy 35 000 Options (right to buy)
INSIDER POWER
100.00
Last 38 transactions
Buy: 2 361 696 | Sell: 57 465

Volumen Korrelation

Lang: -0.15 (neutral)
Kurz: 0.93 (very strong)
Signal:(70.109) Expect same movement, but be aware

Benitec Biopharma Inc Korrelation

10 Am meisten positiv korreliert
RNLX0.862
TTSH0.842
BAFN0.831
OVLY0.829
VIOT0.826
GGAL0.826
ASLE0.824
CASH0.823
BOOM0.82
TELA0.818
10 Am meisten negativ korreliert
MBCN-0.811

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Benitec Biopharma Inc Korrelation - Währung/Rohstoff

The country flag 0.57
( weak )
The country flag 0.48
( neutral )
The country flag 0.00
( neutral )
The country flag 0.62
( weak )
The country flag -0.40
( neutral )
The country flag -0.45
( neutral )

Benitec Biopharma Inc Finanzdaten

Annual 2023
Umsatz: $75 000.00
Bruttogewinn: $-306 000 (-408.00 %)
EPS: $-14.12
FY 2023
Umsatz: $75 000.00
Bruttogewinn: $-306 000 (-408.00 %)
EPS: $-14.12
FY 2022
Umsatz: $73 000.00
Bruttogewinn: $64 000.00 (87.67 %)
EPS: $-38.62
FY 2021
Umsatz: $59 000.00
Bruttogewinn: $-64 000.00 (-108.47 %)
EPS: $-3.23

Financial Reports:

No articles found.

Benitec Biopharma Inc Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A) 		$0
(N/A)

Benitec Biopharma Inc Dividend Information - No Dividend Player

Dividend Sustainability Score: 0 - low (50.00%) | Divividend Growth Potential Score: 0 - No dividend growth expected in the near future
Information
First Dividend $0.0450 2018-06-01
Last Dividend $0.0450 2018-06-01
Next Dividend $0 N/A
Payout Date 2018-06-08
Next Payout Date N/A
# dividends 1 --
Total Paid Out $0.0450 --
Avg. Dividend % Per Year 0.00% --
Score 0.01 --
Div. Sustainability Score 0
Div.Growth Potential Score 0
Div. Directional Score 0 --
Next Divdend (Est)
 (2024-04-29)
$0 Estimate 0.00 %
Dividend Stability
0.01 Very Bad
Dividend Score
0.01
Pay Frequency
Insufficient data to determine frequency
Yearly Payout
Year Amount Yield
2018 $0.0450 0.01%
2019 $0 0.00%
2020 $0 0.00%
2021 $0 0.00%
2022 $0 0.00%
2023 $0 0.00%
2024 $0 0.00%

Dividend Commentary

The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.

Top 10 dividend Companies for NASDAQ

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
PSEC Dividend Royal 2023-12-26 Monthly 21 7.04% 8.50
SLVO Dividend Royal 2023-11-20 Monthly 12 10.77% 8.50
QYLD Dividend Royal 2023-11-20 Monthly 11 7.50% 8.50
GAIN Dividend Royal 2023-12-04 Monthly 20 8.19% 8.50
GLDI Dividend Royal 2023-11-20 Monthly 12 7.15% 8.50
OXLC Dividend Royal 2023-12-14 Monthly 14 10.00% 8.50
OXSQ Dividend Diamond 2023-12-14 Monthly 21 9.10% 8.50
HRZN Dividend King 2023-12-18 Monthly 15 6.60% 8.45
USOI Dividend Royal 2023-11-20 Monthly 8 16.70% 8.28
PFLT Dividend King 2023-11-15 Monthly 14 6.50% 8.27

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM-358.571.500-10.00-10.00[0 - 0.5]
returnOnAssetsTTM-1.0241.200-10.00-10.00[0 - 0.3]
returnOnEquityTTM-2.051.500-10.00-10.00[0.1 - 1]
payoutRatioTTM0-1.00000[0 - 1]
currentRatioTTM3.620.80010.008.00[1 - 3]
quickRatioTTM3.550.80010.008.00[0.8 - 2.5]
cashRatioTTM3.551.50010.0010.00[0.2 - 2]
debtRatioTTM0.0198-1.5009.67-10.00[0 - 0.6]
interestCoverageTTM-1 446.131.000-10.00-10.00[3 - 30]
operatingCashFlowPerShareTTM-7.012.00-2.34-4.67[0 - 30]
freeCashFlowPerShareTTM-7.012.00-3.51-7.01[0 - 20]
debtEquityRatioTTM0.0273-1.5009.89-10.00[0 - 2.5]
grossProfitMarginTTM0.8201.00010.0010.00[0.2 - 0.8]
operatingProfitMarginTTM-355.611.000-10.00-10.00[0.1 - 0.6]
cashFlowToDebtRatioTTM-42.711.000-10.00-10.00[0.2 - 2]
assetTurnoverTTM0.002860.800-3.31-2.65[0.5 - 2]
Total Score-1.934

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM-0.8131.000-0.1830[1 - 100]
returnOnEquityTTM-2.052.50-10.00-10.00[0.1 - 1.5]
freeCashFlowPerShareTTM-7.012.00-2.34-7.01[0 - 30]
dividendYielPercentageTTM01.50000[0 - 0.4]
operatingCashFlowPerShareTTM-7.012.00-2.34-4.67[0 - 30]
payoutRatioTTM01.50000[0 - 1]
pegRatioTTM0.006901.500-3.290[0.5 - 2]
operatingCashFlowSalesRatioTTM-296.161.000-10.000[0.1 - 0.5]
Total Score-3.45

Benitec Biopharma Inc

Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.

Über Live-Signale

Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.

Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.